We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Vircell S.L.

Vircell is a biotechnology company specializing in the development and production of ready-to-use reagents for the di... read more Featured Products: More products

Download Mobile App





Vircell Presents Latest Offerings and Products in Diagnostic Testing

By LabMedica International staff writers
Posted on 12 Nov 2024

Vircell (Granada, Spain) is attending this year’s MEDICA where the company is highlighting its latest offerings as well as upcoming products. More...

At MEDICA 2024, Vircell is highlighting the VirClia Lotus instrument based on its monotest technology to process infectious disease immunoassays for human diagnostic applications. VirClia Lotus accepts any combination of samples and reagents, regardless of the instrument status. Even while running, it remains accessible for reagent and sample addition. VirClia Lotus’ built-in scanner allows for full traceability of both samples and strips, avoiding clerical errors. This true monotest solution allows the laboratory to run low-volume infectious serology tests daily, alongside the laboratory routine. VirClia Lotus unifies all the parameters typically performed with ELISA, IFA or rapid tests in just one chemiluminescent immunoassay (CLIA) system.

Among its wide range of rapid tests, Vircell is showcasing its new ASPERGILLUS GALACTOMANNAN Ag VIRCLIA MONOTEST for the detection of invasive aspergillosis as an aid for the early diagnosis of this life-threatening disease. This sandwich CLIA is intended for the detection of Aspergillus galactomannan antigen in serum, plasma and human bronchoalveolar lavage (BAL) samples. Vircell is also showcasing the HELICOBACTER PYLORI Ag VIRCLIA MONOTEST, an innovative, fully automated single-test format for detecting H. pylori antigen in stool samples. This sandwich CLIA test simplifies sample preparation by eliminating the need for centrifugation, using a tube with a built-in filter instead.

Additionally, Vircell is highlighting the INVASIVE CANDIDIASIS (CAGTA) VIRCLIA IgG MONOTEST for the early detection of invasive candidiasis (IC) that discriminates infection from colonization. This indirect CLIA is intended to detect IgG antibodies against antigens located on the cell wall surface of the micelium of Candida albicans (CAGTA, Candida albicans germ tube antibody) in human serum/plasma. Visitors to the Vircell booth can also learn about the company’s CLIAs to detect antibodies against hepatitis E virus in human serum or plasma samples. These assays offer a complete solution as an aid in the diagnosis of hepatitis E: HEV IgM, HEV IgG, and HEV IgG avidity.

Related Links:
Vircell


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Platelet Function Analyzer
PL-12
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.